key: cord-0991792-vfnptdw4
authors: Pepe, Anna; Pietropaoli, Stefano; Vos, Matthijn; Barba-Spaeth, Giovanna; Zurzolo, Chiara
title: Tunneling nanotubes provide a novel route for SARS-CoV-2 spreading between permissive cells and to non-permissive neuronal cells
date: 2021-11-17
journal: bioRxiv
DOI: 10.1101/2021.11.15.468633
sha: e6c36b08062e44411fb44b1268455b64af679b05
doc_id: 991792
cord_uid: vfnptdw4

SARS-CoV-2 entry into host cells is mediated by the binding of its spike glycoprotein to the angiotensin-converting enzyme 2 (ACE2) receptor, highly expressed in several organs, but very low in the brain. The mechanism through which SARS-CoV-2 infects neurons is not understood. Tunneling nanotubes (TNTs), actin-based intercellular conduits that connect distant cells, allow the transfer of cargos, including viruses. Here, we explored the neuroinvasive potential of SARS-CoV-2 and whether TNTs are involved in its spreading between cells in vitro. We report that neuronal cells, not permissive to SARS-CoV-2 through an exocytosis/endocytosis dependent pathway, can be infected when co-cultured with permissive infected epithelial cells. SARS-CoV-2 induces TNTs formation between permissive cells and exploits this route to spread to uninfected permissive cells in co-culture. Correlative Cryo-electron tomography reveals that SARS-CoV-2 is associated with the plasma membrane of TNTs formed between permissive cells and virus-like vesicular structures are inside TNTs established both between permissive cells and between permissive and non-permissive cells. Our data highlight a potential novel mechanism of SARS-CoV-2 spreading which could serve as route to invade non-permissive cells and potentiate infection in permissive cells.

we looked for productive infection by staining the infected monolayers with a virus-specific 116 antibody and by titrating the virus released in the supernatant. Using these two parameters we 117 found that only the epithelial Vero E6 and Caco-2 cells were susceptible to infection with 118 SARS-CoV-2, as previously shown (46) , while both neuronal cell lines (mouse and human) did The main mediator of cellular entry of SARS-CoV-2 is the ACE2 receptor (1, 24, 47) ; whilst it 131 is highly expressed in vascular endothelial cells of the lungs (47) , it was detected at extremely 132 low levels in the neuronal cells (45). Consistently, we were unable to detect a signal for ACE2 133 in SH-SY5Y cells ( fig. S2 ), confirming previous observation reporting extremely low levels of 134 expression in neuronal cells (45) . Nonetheless, emerging case reports showed that patients 135 infected with SARS-CoV-2 have common neurological manifestation (17, (48) (49) (50) (51) (52) (53) suggesting 136 that the virus could invade and infect the CNS (7, 53, 54) . Since the ACE2 receptor is not widely 137 expressed in neuronal cells one likely possibility is that the virus can exploit intercellular 138 communication pathways to enter neuronal cells directly from permissive cells, which would 139 allow bypassing the main receptor mediated pathway. To investigate this, we set up co- of fully assembled virions we would have expected to find them in acceptor cells already at 24h 169 of co-culture, which was not the case. 170

To directly investigate whether SARS-CoV-2 transferred from the donor cells was still 171 functional, and able to replicate in neuronal cells, we performed an immunostaining using the 172 anti-dsRNA (double-stranded RNA) antibody J2 that is the gold standard for the detection of 173 dsRNA in infected cells (57). After 48h of co-culture (Vero E6 infected cells as donors and SH-174 SY5Y cells as acceptors), cells were fixed and immunostained to detect dsRNA and SARS-175

CoV-2 particles using the anti-S antibody. We found J2 positive signal both in donor Vero E6 176 infected cells and acceptor SH-SY5Y cells ( Fig. 2A-C) . Interestingly, J2 signal in SH-SY5Y 177 cells (Fig. 2B , C) corresponds to bright foci of different sizes and intensities, that could 178 represent the replication organelles (RO) or double-membrane vesicle (DMVs) where viral 179 RNA synthesis occurs (58, 59) . Furthermore, the localization of J2 spots in the perinuclear/ER 180 region of acceptor cells could suggest an active viral replication occurring in the neuronal cells 181 was not detected in non-infected Vero E6 co-cultured with SH-SY5Y mCherry (Fig. 2D ), as 183 well as, in the negative control in which the co-culture was incubated only with the secondary 184 antibody (Fig. 4E) . These data indicate that SARS-CoV-2 transferred by a cell-to-cell contact-185 dependent mechanism could be actively replicated in neuronal acceptor cells. 186

To support this hypothesis, as complementary approach we performed an immunostaining 187 against the non-structural protein 3 (nsp3), an essential component of the viral 188 replication/transcription complex. After 48h of co-culture (Vero E6 infected cells as donors and 189 SH-SY5Y cells as acceptors), cells were fixed and immunostained to detect nsp3 and SARS-190

CoV-2 particles (by anti-N). We found cytoplasmic accumulations containing the viral N 191 protein and the non-structural protein nsp3 both in donor Vero E6 and acceptor SH-SY5Y cells 192 ( Fig. 3A-D) . This data confirms that SARS-CoV-2 can replicate in the acceptor neuronal cells. 193

The above data show that neuronal cells can be infected when in co-culture with permissive 194 cells, but do not address the mechanism. Although our data show that SH-SY5Y cells cannot 195 be infected by the supernatant (fig S1) , in order to investigate the possible contribution of the 196 endocytic entry pathway in co-culture conditions, as control for the co-culture experiments, we 197 performed "secretion tests" were the supernatants from Vero E6 infected cells were used to 198 infect SH-SY5Y cells for 24h and 48h respectively ( fig. S4A ). We did not detect any signal for The results described above provide evidence that while SARS-CoV-2 entry into epithelial cells 210 is mediated by the classical exo/endocytosis pathway, the spreading between permissive 211 cells and non-permissive neuronal cells could occur in a direct cell-to-cell contact dependent 212 manner. Recent studies have shown that viruses of many different families, including 213 retroviruses such as HIV, and enveloped viruses like herpesviruses, orthomyxoviruses, and 214 several others trigger the formation of TNTs or TNT-like structures in infected cells and use 215 these structures to efficiently spread to uninfected cells (39). We therefore explored whether 216

TNTs could be a mechanism involved in the spreading of SARS-CoV-2 to non-permissive 217 neuronal cells. To detect TNTs between Vero E6 and SH-SY5Y cells we used cell Mask Blue, 218

which stains the entire cell cytosol and outlines the entire cell shape. To properly identify TNTs 219 by confocal microscopy it is crucial to distinguish them from other actin driven membranous 220 protrusions such as filopodia (65,66). TNTs hover above the substrate and even over other cells, 221 and unlike dorsal filopodia, TNTs are able to connect two or more distant cells. Based on these 222 criteria, first we assessed the presence of TNTs in control co-culture between Vero E6 cells and 223 SH-SY5Y cells expressing the NLS-GFP (Nucleal Localization Signal) and stained with 224 rhodamine phalloidin (for cellular membrane and actin labelling). We observed heterotypic 225

TNTs formed between Vero E6 cells and SH-SY5Y NLS-GFP ( fig. S5A, B) . Strikingly, we 226 also observed TNTs between SARS-CoV-2 infected Vero E6 donor cells and mCherry-SH-227 SY5Y acceptor cells in co-culture that contained particles stained with anti-N antibody, which 228 were also found inside the cytoplasm of the acceptor neuronal cells (Fig. 4 A, B ). In addition, 229

we found TNTs between SH-SY5Y acceptor cells, which also contained anti-N labelled 230 particles (Fig. 4 C, D) . Altogether the data presented above (Fig 1-4) indicate that SARS-CoV- 

Next, we wanted to identify the nature and structure of the viral particles shared by TNTs and 238

investigate the mechanisms allowing their TNT-mediated transfer to non-permissive cells (eg, 239 whether the infectious particles were using TNTs as membrane bridges to surf on top, or as 240 channels to be transferred inside the tube). To this aim we set up a correlative fluorescence and 241 cryo-electron microscopy and tomography approach (CLEM, cryo-EM and cryo-ET) (35). 242

These techniques allowed us to assess for the first time in correlative mode, both SARS-CoV- TNTs (for details see material and methods). Consistent with our previous data, we detected 249

TNTs between Vero E6 and SH-SY5Y mCherry (Fig. 5A, 5F ). By using the grid finders after Since SARS-CoV-2 replication is associated with proliferation of membranes and presence of 263

DMVs where viral replication is taking place (58) , it is possible that these structures represent 264 viral replicative complexes being transferred to the acceptor cells. 

Altogether, these data suggested that TNT can allow the intercellular spreading of the infection 268 from permissive to non-permissive cells. Next, we wondered whether the TNT-mediated route 269 dedicated to invading non-permissive cells could also be used to enhance the spreading of the 270 virus between permissive cells in addition to the endocytic route. We therefore analysed 271 whether SARS-CoV-2 exploits TNTs for cell-to-cell spread between Vero E6 cells ( Fig. 6A -272 C). By confocal microscopy, we observed that in uninfected Vero E6 a low percentage of cells 273

were connected by TNTs (Fig. 6A , C), but this percentage was substantially increased already 274 after 24h of SARS-CoV-2 infection (Fig. 6B, C) . Strikingly, after immunostaining using either 275 the anti N antibody (Fig. 6B ) and anti S (Fig. 6D ) alone or both anti N and anti S antibodies 276 Therefore, a concentration of 10 µg/ml was set as the minimal concentration to investigate cell-290

to-cell transfer in Vero E6 cells. 291

As usual, Vero E6 cells were infected with SARS-CoV-2 MOI 0,05 (donor cells) for 48 hours, 292 but then incubated with 10 µg/ml anti-SARS-CoV-2 IgG C3 235 for 1 hour at 37°C 5% CO2, 293 prior co-culturing in presence of the antibody, with Vero E6 cells expressing mCherry (acceptor 294 cells), to distinguish them from the infected donor population. After 24h and 48h hours cells 295

were fixed and immunostained with anti-N antibody. By using confocal microscopy and ICY 296 Furthermore, the supernatants of each condition were collected to determine the virus 309 concentration using the focus forming assay (Fig. 7 G) . 310

These data show that despite the block of the receptor-mediated virus entry, Vero E6 cells could 311 be infected when put in co-culture with infected cells, indicating that SARS-CoV-2 can spread 312 also between permissive cells through a secretion-independent pathway. 313 314

To uncover the nature of the particles labelled with anti-N and anti-S antibodies in TNTs by 316 fluorescence microscopy and to discriminate if they were localised inside or on top of TNTs 317 between permissive cells we used again correlative fluorescence cryo-EM and cryo-ET (35). 2). Considering that cryo-ET resolution is limited by the thickness of the sample, and the fact 354 that TNTs described here have an average diameter of more than 500 nm, we were at the 355 resolution limits and we were not able to discriminate the precise structures of these vesicular 356 compartments. Therefore, besides stating the fact that these structures were found in 357 correspondence of S antibody, we cannot be sure whether they are mature virions as the ones 358 observed outside the TNTs. Our study is carried out using Vero E6 cell line as epithelial model since it has been widely 367 employed for SARS-CoV-2 isolation, propagation, and antiviral testing, due to its high virus 368 production and a prominent cytopathic effect (CPE) upon infection (46) . Our choice of SH-369 SY5Y cell line as neuronal model of non-permissive cells is justified not only because these 370 cells are human and widely used as neuronal model, but also because we have thoroughly 371 characterized their TNTs (35) and able to identify them with high reliability (35,74). An ideal 372 neuronal model could be represented by primary neurons, however in primary neurons it is very 373 difficult to discriminate TNT-like structures (32) and it is even more challenging to apply 374 correlative cryo-light and electron microscopy and-tomography approach. In the future it will 375 be important to confirm these data using a different neuronal model like iPSC-derived human 

The aliquots of supernatant collected at day 2 and day 3 were used to assess viral production 433 through a semisolid plaque assay. Each sample underwent 1:10 serial dilutions. 250 µl of each 434 dilution was used to infect a confluent monolayer of Vero E6 cells, in a 24 wells multiwell 435 plate, for a total of 6 wells per sample. 436 Viral absorption was allowed for 1 hour at 37°C, and a semisolid overlay, composed by MEM 437 1X, 10% FBS and 0.8% agarose, was then added to the infection (250 µl per well). The cells 438

were incubated at 37°C 5% CO2 for 72 hours. Finally, the infected monolayers were fixed with 439 500 µl of 4 % PFA for 30 minutes. Afterward, the PFA was removed and the monolayers were 440 then stained with Crystal Violet solution containing 2 % PFA, to evaluate the cytopathic effect. 441

The reaction was stopped after 15 mins and residual Crystal violet was removed through 442 immersion in diluted bleach, followed by washing in water. Paris] which it has been proved to be sufficient to elicit complete neutralization for a viral 539 concentration of 1-5 x 10 5 FFU/ml. Donor cells were incubated in presence of the antibody for 540 1 hour at 37°C 5% CO2. Afterward, donor cells were co-cultured in a ratio 1:1 with mCherry-541

Vero -E6 acceptor cells in DMEM 5% FBS with 10 ug/ml of the afore mentioned neutralizing 542 antibody. The co-cultures were incubated for 24 and 48h hours 37°C 5% CO2. Then, co-543 cultures were fixed in 4% PFA for 30 min and immunostained for the anti-N (protocol described 

The cryo-EM data was collected from different grids at the Nanoimaging core facility of the 591 Institut Pasteur using a Thermo Scientific Titan Krios G3i electron microscope with a Gatan 592

Bioquantum energy filter and K3 detector. Tomography software from Thermo Scientific was 593 used to acquire the data. Tomograms were acquired using dose-symmetric tilt scheme (75), a 594 +/-60 degree tilt range with a tilt step 2 was used to acquire the tilt series. Tilt images were 595 acquired in counting mode with a calibrated physical pixel size of 3.2 Å and total dose over the Graph in the Figure 1D showing the percentage of N transfer in co-culture at 24h and 48h. 620

Mean percentage of N transfer in co-culture 24h: 36.47% ± 3.96, co-culture 48h: 62.56% ± 621 8.28, (p=0.0468 (*) for co-culture 48h versus co-culture 24h; N=3). Graph in the Figure 1G Control versus co-culture 48h plus neutralizing antibody. p=0.9914 (ns) for co-culture 24h 635

Control versus co-culture 48h control. p=0.0122 (*) for co-culture 24h Control versus co-636 culture 48h plus neutralizing antibody. p=0.0016 (**) for co-culture 24h control antibody 637 versus co-culture 48h plus neutralizing antibody. p=0.0496 (*) for co-culture 24h plus 638 neutralizing antibody versus co-culture 48h plus neutralizing antibody. Mean percentage of N 639 transfer in secretion 24h Control: 100% ± 0 versus co-culture 24h plus neutralizing antibody 0 640 ± 0; p=0.0005 (***) for co-culture 24h Control versus co-culture 24h plus neutralizing 641 antibody. Mean percentage of N transfer in secretion 48h Control: 80% ± 10 versus co-culture 642 48h plus neutralizing antibody 0 ± 0; p=0.0008 (***) for co-culture 48h Control versus co-643 culture 48h plus neutralizing antibody. Graph in the Supplementary Figure 4C 

A pneumonia outbreak 680 associated with a new coronavirus of probable bat origin

SARS-CoV-2 infection of the 684 oral cavity and saliva

A Novel Coronavirus from Patients with 687 Pneumonia in China

Neurologic Manifestations of Hospitalized 690 Patients With Coronavirus Disease

Neuroinvasion of 693 SARS-CoV-2 in human and mouse brain

Clinical features of patients infected with 695 2019 novel coronavirus in Wuhan, China. The Lancet

Neurotropism of SARS-CoV 2: Mechanisms and manifestations

Characterizing Long COVID 703 in an International Cohort: 7 Months of Symptoms and Their Impact. medRxiv

Long COVID' syndrome

Characteristics 710 of Long Covid: findings from a social media survey

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of 715 Coronavirus Disease 2019: A Review

Profile of a killer: the complex biology powering the coronavirus pandemic

720 Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

725 Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. 726

Human Pluripotent 728 Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism. 729 bioRxiv

SARS-CoV-2 Infects 732 the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids

Multiorgan and Renal Tropism of SARS-CoV-2

A first case of 738 meningitis/encephalitis associated with SARS-Coronavirus-2

Olfactory 741 transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in 742 individuals with COVID-19

CoV-2 Infection and Pathogenesis

Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on 749

Neurological Impairments and Manifestations

Villegas-Rojas 752 MM, León-Aguilar AM, et al. Elucidating the Neuropathologic Mechanisms

The proximal origin of SARS-756

CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven 760

Mechanisms of SARS-CoV-2 entry into cells

The Spatial and Cell-Type 767 Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains

Brain Invasion and Histopathology in COVID-19 Disease

The spread of prion-like proteins by lysosomes and tunneling 775 nanotubes: Implications for neurodegenerative diseases

Parkinson's disease: the dual hit theory revisited. Ann 779 N Y Acad Sci

Prions hijack 781 tunnelling nanotubes for intercellular spread

Tunneling nanotubes 783 spread fibrillar α-synuclein by intercellular trafficking of lysosomes

The Wnt/Ca2+ pathway 786 is involved in interneuronal communication mediated by tunneling nanotubes

Nanotubular highways for 789 intercellular organelle transport

Peering into tunneling nanotubes-The path forward. 791 EMBO J

Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells

Wiring through tunneling nanotubes--from electrical signals to 797 organelle transfer

Intercellular transfer mediated by tunneling nanotubes

Tunneling nanotubes (TNT) are induced by HIV-801 infection of macrophages: a potential mechanism for intercellular HIV trafficking

Bridging the Gap: Virus Long-Distance Spread 804 via Tunneling Nanotubes

Human Immunodeficiency Virus type 1 Endocytic Trafficking 806

Through Macrophage Bridging Conduits Facilitates Spread of Infection

Tuberculosis 810 Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube 811 Formation in Macrophages

Membrane nanotubes physically connect T cells over long distances presenting a novel 814 route for HIV-1 transmission

Receptor Recognition by the Novel Coronavirus 816 from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Isolation and characterization 819 of a bat SARS-like coronavirus that uses the ACE2 receptor

The neuroinvasive potential of SARS-CoV2 may play a role in 823 the respiratory failure of COVID-19 patients

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid 828 adaptation and cytopathology

How does SARS-CoV-2 cause COVID-19? Science

Epidemiological and clinical 832 characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a 833 descriptive study. The Lancet

Neurologic 837 Features in Severe SARS-CoV-2 Infection

Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology

Guillain Barre syndrome associated with COVID-19 infection: A case 842 report

Guillain-Barré Syndrome 844 associated with SARS-CoV-2 infection

Early postmortem brain 846 MRI findings in COVID-19 non-survivors

Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2

SARS-CoV-2) and the Central Nervous System

Coronavirus biology and replication: 854 implications for SARS-CoV-2

Double-Stranded RNA Is Detected by Immunofluorescence 857 Analysis in RNA and DNA Virus Infections, Including Those by Negative-Stranded RNA 858

CoV-2 structure and replication characterized by in situ cryo-electron tomography

865 A molecular pore spans the double membrane of the coronavirus replication organelle

SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network

A unifying structural and functional model of the coronavirus replication organelle: 875 Tracking down RNA synthesis

Infectious 877 bronchitis virus generates spherules from zippered endoplasmic reticulum membranes. 878 mBio

Qualitative and quantitative 880 ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell 881 Microbiol

Molecular interactions in the assembly of coronaviruses

Differential identity 885 of Filopodia and Tunneling Nanotubes revealed by the opposite functions of actin 886 regulatory complexes

Identification and Characterization of Tunneling 889 Nanotubes for Intercellular Trafficking

Cryo-EM structure of the SARS coronavirus spike 892 glycoprotein in complex with its host cell receptor ACE2

The Architecture of Inactivated 896 SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET

Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution 904 scanning electron microscopy

Actin-and myosin-driven 907 movement of viruses along filopodia precedes their entry into cells

Human 910 metapneumovirus Induces Reorganization of the Actin Cytoskeleton for Direct Cell

Global Phosphorylation Landscape of SARS-CoV-2 Infection

Effect of 919 tolytoxin on tunneling nanotube formation and function. Sci Rep

Implementation of a cryo-electron tomography tilt-921 scheme optimized for high resolution subtomogram averaging

Green square in (C) 1000 corresponds to the high-magnification of cryo-tomogram slices in (D) showing a TNT 1001 containing vesicular compartments and double membrane vesicles (DMV). (E) Enlargement of 1002 cryo-tomogram slices in (D). (F-K) Cryo-EM grids were prepared using Vero E6 infected cells 1003 co-cultured with SH-SY5Y mCherry cells and

F) low (G) and intermedia (H) magnification TEM. (I) Slices of tomograms of 1006 TNT in the green square in (H) showing vesicular compartments inside TNT. (J, K) High-1007 magnification cryo-tomography slices corresponding to the yellow dashed squares showing 1008 vesicular compartments inside TNT

SARS-CoV-2 infection increases TNTs between infected Vero-E6 cells

Confocal micrograph showing TNTs between non-infected Vero E6 cells. (B) Confocal 1018 micrograph showing TNTs between Vero E6 cells SARS-CoV-2 infected cells. Anti-N 1019 immunostaining is performed to detect SARS-CoV-2. The yellow arrows indicate TNTs 1020 between VeroE6 cells

Graph showing the percentage of TNT-connected cells between Vero E6 cells non-infected 1022 and SARS-CoV2-infected. Mean percentage of TNT-connected Vero E6 non-infected cells

95% ± 2.46. Mean percentage of TNT-connected SARS-CoV-2-infected Vero E6 cells

0006 for SARS-CoV-2-infected Vero E6 cells versus Vero E6 non-1025 infected; N=3). (D) Confocal micrograph and 3D rendering showing TNTs

CoV-2-infected Vero E6 cells; an anti-S immunostaining was performed to detect SARS-CoV-1027 2. The yellow arrow indicates a TNT between Vero E6

SARS-CoV-2 associated to a TNT. (E) Confocal micrograph showing TNTs between Vero E6 1029 cells SARS-CoV-2 infected cells labelled with cell Mask blue. Anti-N (633) and anti-S

immunostaining was performed to detect SARS-CoV-2. The yellow arrows indicate a TNT 1031 between infected VeroE6 cells; the white and the green arrows indicate SARS-CoV2 particles 1032 inside TNTs

SARS-CoV-2 spread through TNTs between permissive cells. (A) Vero E6 infected 1038 donor cells were put in co-culture at 1:1 ratio with Vero E6 mCherry acceptors in control 1039 conditions (without neutralizing antibody) and (B) in neutralizing conditions

E6 infected cells were incubated with 10 µg/ml of anti-SARS-CoV-2 IgG C3 235 for 1 hour at 1041

The co-cultures 1042 were fixed after 48h of incubation at 37°C 5% CO2 and immunostained with anti-N antibody 1043 to detect SARS-CoV-2. (C) Graph showing the mean percentage of N puncta transferred in co-1044 culture at 24h and 48h, treated and not with the neutralizing antibody

Vero E6 mCherry cells were incubated with the supernatant deriving from donor Vero E6 1050 infected cells. (E) The supernatant from donor Vero E6 infected cells was incubated with 10

ug/ml of the anti-SARS-CoV-2 IgG C3 235 for 1h at 37°C, in order to neutralize the viral 1052 particles, before to be added on top of Vero E6 mCherry acceptor cells. After 48h of incubation 1053

Graph 1054 showing the mean percentage of N puncta contained in acceptor cells in the secretion 1055 experiments at 24h and 48h, treated or not with the neutralizing antibody

0008 48h control versus 48h plus neutralizing antibody). (G) Supernatant of each 1059 condition was then collected to assess viral neutralization using Focus Forming Assay (FFA) 1060 titration protocol

Correlated light and cryo-electron microscopy strategies reveal SARS-CoV-2 on top 1066

of TNTs between infected Vero E6 cells. (A) TNT-connected Vero E6 infected SARS-CoV-1067 2 cells stained with WGA (green) and acquired by confocal microscopy (A) low (B)

intermediate (C) magnification TEM. (D) Slices of tomograms of TNT in green square in (C)

showing extracellular SARS-CoV-2 on top of the TNT connecting Vero E6 cells. (E-F) High-1070 magnification cryo-tomography slices corresponding to the yellow dashed squares in (D)

High-magnification cryo-tomography 1073 slices showing the extracellular virions on TNT

Correlative IF cryo-EM strategies to discriminate SARS-CoV-2 localization in 1080

A-L Cryo-EM grids were prepared using Vero E6 infected cells (A) Confocal 1081 micrograph showing TNT connecting infected Vero E6 cells stained with anti-S antibody 1082 (green) and cell mask blue. Low (B) and intermediate (C) magnification TEM of (A)

High-magnification cryo-tomography slices showing vesicular compartments in 1084 correspondence of anti-S signal and SARS-CoV-2 like structure on TNT surface

Enlargement of the high-magnification cryo-tomography slices (D-E) showing SARS-CoV-2 1086 like structure on TNT surface (J-L) Enlargement of the high-magnification cryo

D-E) showing viral like structure inside TNT. RNP proteins and Spike are observed

Pink arrowheads indicate the spike

SARS-CoV-2 like structure inside vesicles. Scale bars

Plateforme Technologique Nanoimagerie Institut Pasteur, 25 rue du Docteur Roux

Catalent Phama Solution, Strada Provinciale 12 Casilina, 41, 03012

E-mail: chiara.zurzolo@pasteur.fr (CZ)

Supplementary Fig. 2. ACE2 receptor expression. (A) Confocal micrograph displaying Hela

SH-SY5Y and Vero E6 cells labeled with an anti-ACE2 antibody (green) and cell mask blue. 32 Scale bars: a 15 µm

Supplementary Fig. 5. TNTs are formed between Vero E6 cells and SH-SY5Y cells

Representative confocal micrograph displaying TNT between Vero E6 cells and GFP NLS SH-70 SY5Y cells. Cells were stained with Phalloidin Rhodamine (red) to label the plasma membrane 71

DAPI (blue) to label the nuclei. (B) 3D rendering of (A)

Supplementary Fig. 8. SARS-CoV-2 on TNTs connected Vero E6 infected cells

Low (A) and intermediate (B) magnification of an electron micrograph of TNT-connected 97

High magnification cryo-ET slice corresponding to 98 the green rectangle in (B). (D, E and F) High-magnification cryo-tomography slices showing 99 the extracellular virions on TNT. Pink arrowheads indicate the spike on SARS-CoV2

The monolayers were infected with 300 ul of the pre-treated stock with C3-235 antibody After 48h Supernatants were collected and titrated using Focus forming assay, to verify viral production inhibition.The monolayers were fixed for IF.